Affinity Investment Advisors’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-16,140
Closed -$261K 195
2023
Q3
$261K Buy
16,140
+51
+0.3% +$905 0.17% 167
2023
Q2
$306K Sell
16,089
-321
-2% -$5.72K 0.18% 168
2023
Q1
$239K Buy
16,410
+128
+0.8% +$2.29K 0.13% 174
2022
Q4
$318K Sell
16,282
-3,834
-19% -$74.8K 0.15% 161
2022
Q3
$485K Hold
20,116
0.25% 135
2022
Q2
$633K Sell
20,116
-540
-3% -$19.6K 0.31% 111
2022
Q1
$909K Sell
20,656
-4,389
-18% -$188K 0.37% 99
2021
Q4
$1.09M Buy
25,045
+96
+0.4% +$3.76K 0.44% 73
2021
Q3
$781K Buy
24,949
+95
+0.4% +$3.74K 0.35% 107
2021
Q2
$1.05M Hold
24,854
0.47% 73
2021
Q1
$934K Buy
24,854
+112
+0.5% +$3.5K 0.34% 88
2020
Q4
$669K Buy
+24,742
New +$636K 0.27% 105

Other funds holding ACH

Affinity Investment Advisors's ACH Position: Q4 2023 in Review

Affinity Investment Advisors sold out of Accendra Health (ACH) in Q4 2023, closing a stake of 16,140 shares — an estimated $261K sold.

Affinity Investment Advisors first reported a position in ACH in Q4 2020 and held it in 12 quarters. The position peaked at $1.09M in Q4 2021. 227 funds tracked by Wall St. Rank hold ACH as of Q4 2023.

  • Affinity Investment Advisors reported no remaining Accendra Health position as of Q4 2023 after selling out during the quarter.
  • Affinity Investment Advisors sold 16,140 Accendra Health shares in Q4 2023, an estimated $261K.
  • Affinity Investment Advisors first reported a position in Accendra Health in Q4 2020 and held it in 12 quarters.
  • Affinity Investment Advisors's Accendra Health position peaked at $1.09M in Q4 2021.
  • 227 funds tracked by Wall St. Rank held Accendra Health as of Q4 2023.

Based on Affinity Investment Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.